Celebrex shows potential in preventing some skin cancersDecember 1st, 2010 - 3:16 pm ICT by ANI
Washington, Dec 1 (ANI): A new study has shown that the NSAID Celebrex may help prevent some non-melanoma skin cancers from developing in patients who have pre-cancerous actinic keratoses lesions and are at high risk for having the disease.
The research team, led by University of Alabama at Birmingham senior scientist Craig Elmets, evaluated the efficacy and safety of celecoxib as a chemo-preventive agent for actinic keratoses.
In animal models, the cyclooxygenase 2 inhibitor celecoxib, better known by its brand name Celebrex, inhibits the development of ultraviolet-induced pre-malignant skin papillomas, which are thought to correspond to actinic keratoses, the pre-malignant precursor of non-melanoma skin cancers
Currently, celecoxib is used to relieve pain, tenderness, swelling and stiffness caused by osteoarthritis, rheumatoid arthritis and spinal arthritis.
The double-blind, placebo-controlled trial looked at 240 subjects ages 37 to 87 years with 10 to 40 actinic keratoses at eight U.S. academic medical centers during an 11-month period.
At nine months after randomization, there was no difference in the incidence of new actinic keratoses developed between the placebo group and those receiving celecoxib, which was the primary endpoint of the study.
However, compared with the placebo, celecoxib when looked at duing the 11-month visit was highly effective in preventing nonmelanoma skin cancers from developing in subjects who had large numbers of actinic keratoses.
The results were published online Nov. 30, 2010, in the Journal of the National Cancer Institute. (ANI)
- Widely used arthritis pill shows promise against skin cancer - Dec 03, 2010
- Oral and topical agents prevents UV-induced skin cancer - Aug 06, 2010
- Arthritis drug could help treat skin cancer - Mar 24, 2011
- Zebrafish offers skin cancer clues - Apr 06, 2011
- Biomarker test shows promise for diagnosis of melanoma - Jan 25, 2011
- Skin lesion leads to more cancer forms than previously thought - Jun 03, 2009
- Vitamin pill a day keeps cancer at bay! - Mar 03, 2012
- Popping vitamin pills can lead to skin cancer - Sep 28, 2010
- Broccoli and brussels sprouts boost sunscreens' cancer fighting abilities - Apr 27, 2011
- Vitiligo sufferers 'may have natural skin cancer protection' - Apr 22, 2010
- Rich, young women 'more prone to melanoma' - Mar 22, 2011
- 'Co-conspirator' cells may hold key to skin cancer prevention - Aug 31, 2010
- Cancer research finds two genetic variants - Oct 10, 2011
- Vigilance against skin cancer may lead to vitamin D deficiency - Oct 19, 2010
- Twin viruses linked to prostate cancer - Aug 03, 2012
Tags: academic medical centers, actinic keratoses, alabama at birmingham, animal models, celebrex, celecoxib, controlled trial, cyclooxygenase, double blind placebo, endpoint, journal of the national cancer institute, national cancer institute, nonmelanoma skin cancers, papillomas, placebo group, preventive agent, randomization, rheumatoid arthritis, spinal arthritis, university of alabama at birmingham